AZN vs SI · P/E 28, $288.38B cap vs rev $47.3M
AstraZeneca PLC (AZN) versus Shoulder Innovations, Inc. (SI) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Shoulder Innovations, Inc. (SI) common stock listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported SI revenue for 2025-12-31 was $47.3M. Net income was -$40.4M. Revenue was up 49.6% from 2024-12-31 to 2025-12-31. SI currently screens at market cap $369.7M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SI currently screens at market cap $369.7M.
Not investment advice. Open the AZN and SI stock pages for the full models.
Not investment advice.